Endocrinology Drugs Industry Forecasted for Rapid Expansion, Reaching $26.37 Billion by 2029

 Unlock 20% Off Global Market Reports Using Code ONLINE20 — Stay Informed on Trade Policies, Market Growth, and Key Disruptors

 



 What Is the Forecasted Market Size of the Endocrinology Drugs Market by 2029?
 The endocrinology drugs market size has declined marginally in recent years. It will grow from $26.29 billion in 2024 to $26.2 billion in 2025 at a compound annual growth rate (CAGR) of -0.3%. The growth in the historic period can be attributed to increasing prevalence of diabetes globally, increasing government initiatives, increasing healthcare expenditure, increasing prevalence of adrenal gland disorders, a rise in demand for insulin analogs, and growth in the number of endocrinologists.
 
 The endocrinology drugs market size is expected to see marginal growth in the next few years. It will grow to $26.37 billion in 2029 at a compound annual growth rate (CAGR) of 0.2%. The growth in the forecast period can be attributed to a growing diabetic population, increasing prevalence of endocrine disorders, a growing number of adolescents with hormonal imbalances, and rising obesity rates. Major trends in the forecast period include technological advancements, adoption of advanced drug delivery systems, integration of digital health solutions, precision medicine, and combination therapies.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp
 
 Which Factors Are Driving Growth in the Endocrinology Drugs Market?
 The rising prevalence of endocrine diseases is expected to propel the growth of the endocrinology drugs market going forward. Endocrine diseases are disorders that impact the endocrine system, causing imbalances in hormone production or regulation, which can interfere with normal bodily functions. The rising prevalence of endocrine diseases can be attributed to several factors, including lifestyle changes, an aging population, and improved diagnosis, which have all contributed to the increased recognition and incidence of these conditions. Endocrinology drugs help manage endocrine diseases by regulating hormone levels, addressing glandular dysfunction, and restoring hormonal balance to alleviate symptoms and improve overall health outcomes. For instance, in May 2023, according to the National Library of Medicine, a US-based medical library, approximately 13 million people in the United States, or 4.78% of the population, suffer from undiagnosed endocrine disorders. Among these, thyroid disease is one of the most prevalent endocrine disorders, accounting for approximately 20% to 40% of patients treated in endocrine practices. Therefore, the rising prevalence of endocrine diseases is driving growth in the endocrinology drugs market.
 
 What Are the Key Segments in the Endocrinology Drugs Market?
 The endocrinology drugs market covered in this report is segmented — 
 
 1) By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications
 2) By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas
 3) By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies
 4) By End User: Hospitals, Ambulatory Surgical Centers, Others End Users
 
 Subsegments:
 1) By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers 
 2) By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies 
 3) By Diabetes: Insulin Therapies, Oral Antidiabetic Drugs (OADs), GLP-1 Receptor Agonists, SGLT-2 Inhibitors, DPP-4 Inhibitors 
 4) By Polycystic Ovarian Syndrome (PCOS): Oral Contraceptives, Metformin, Clomiphene Citrate, Anti-Androgens 
 5) By Growth Hormone Disorders: Recombinant Human Growth Hormone (rhGH), Growth Hormone Secretagogues, Growth Hormone Receptor Antagonists 
 6) By Pituitary Gland Disorders: Somatostatin Analogs, Gonadotropins, Dopamine Agonists 
 7) By Other Indications: Adrenal Gland Disorders, Osteoporosis, Parathyroid Disorders, Male Hormonal Imbalances 
 
 What Are the Top Trends Expected to Shape the Endocrinology Drugs Market by 2029?
 Major companies operating in the endocrinology drugs market are focusing on developing innovative products such as ready-to-use vials to improve medication administration. Ready-to-use vials are pre-filled and pre-dosed medication containers that require no reconstitution or preparation before administration. For instance, in December 2022, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched Levothyroxine sodium injection in ready-to-use vials at a concentration of 100 mcg/mL. The formulation is designed for immediate use, eliminating the need for reconstitution and reducing the risk of preparation errors, thereby improving patient safety. It provides precise and consistent dosing, which is critical for managing conditions like hypothyroidism and myxedema coma. The ready-to-use vials also improve efficiency for healthcare providers, saving time and ensuring accurate administration in urgent care settings.
 
 Who Are the Leading Players in the Endocrinology Drugs Market?
 Major companies operating in the endocrinology drugs market are Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited 
 
 Get the full endocrinology drugs market report here:
 https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report
 
 What Are the Key Regional Trends in the Endocrinology Drugs Market?
 North America was the largest region in the endocrinology drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrinology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more